Myasthenia gravis (MG) is an autoimmune neuromuscular disorder which is characterized
by presence of antibodies against acetylcholine receptors (AChRs) or other proteins of the …

Statins are drugs widely prescribed in high-risk patients for cerebrovascular or
cardiovascular diseases and are, usually, safe and well tolerated. However, these drugs …

Acquired myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction
in which patients experience fluctuating skeletal muscle weakness that often affects selected …

Serum albumin (SA), the most abundant soluble protein in the body, maintains plasma
oncotic pressure and regulates the distribution of vascular fluid and has a range of other …

Background Myasthenia gravis (MG) is the most common primary disorder of neuromuscular
transmission, but the incidence of MG in China is unknown. We conducted the first …

Statins inhibit 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase, the rate-
limiting enzyme in cholesterol biosynthesis, which converts HMG-CoA to mevalonate …

Myasthenia gravis (MG) is an autoimmune disorder leading to skeletal muscle weakness
and fatigability. MG subgroups are defined according to pathogenetic autoantibody (against …

HMG-CoA reductase inhibitors ('statins') represent the most effective and widely prescribed
drugs currently available for the reduction of low-density lipoprotein cholesterol, a critical …

Drugs used for therapeutic interventions either alone or in combination may sometimes
cause unexpected toxicity to the muscles, resulting in a varying degree of symptomatology …

Statins have a variety of myotoxic effects and can trigger the development of inflammatory
myopathies or myasthenia gravis (MG) mediated by immunomodulatory properties …